QC
AGIO icon

Quent Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Quent Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23
Closed -$1K – 1325
2022
Q3 		$1K Hold
23
– – ﹤0.01% 1130
2022
Q2 		$1K Hold
23
– – ﹤0.01% 1082
2022
Q1 		$1K Buy
+23
New +$703 ﹤0.01% 1175

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quent Capital's AGIO Position: Q4 2022 in Review

Quent Capital sold out of Agios Pharmaceuticals (AGIO) in Q4 2022, closing a stake of 23 shares — an estimated $1K sold.

Quent Capital first reported a position in AGIO in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 159 funds tracked by Wall St. Rank hold AGIO as of Q4 2022.

  • Quent Capital reported no remaining Agios Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Quent Capital sold 23 Agios Pharmaceuticals shares in Q4 2022, an estimated $1K.
  • Quent Capital first reported a position in Agios Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • Quent Capital's Agios Pharmaceuticals position peaked at $1K in Q3 2022.
  • 159 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2022.

Based on Quent Capital's 13F filing for Q4 2022, filed 19 Jan 2023.